Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis
- PMID: 15673774
- PMCID: PMC547215
- DOI: 10.1128/AAC.49.2.804-807.2005
Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis
Abstract
A simple fibroblast-based assay (SFA) was found to be efficient in evaluating the susceptibilities of clinical isolates of Mycobacterium tuberculosis to pyrazinamide (PZA). Forty-five clinical isolates were examined. The MICs of PZA for susceptible strains in an SFA were between 3.13 and 12.5 microg/ml, and the MICs of PZA for resistant strains were more than 100 microg/ml.
References
-
- Alcaide, F., and A. Telenti. 1997. Molecular techniques in the diagnosis of drug-resistant tuberculosis. Ann. Acad. Med. Singapore 26:647-650. - PubMed
-
- Aono, A., K. Hirano, S. Hamasaki, and C. Abe. 2002. Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test. Diagn. Microbiol. Infect. Dis. 44:347-352. - PubMed
-
- Carlone, N. A., G. Acocella, A. M. Cuffini, and M. Forno-Pizzoglio. 1985. Killing of macrophage-ingested mycobacteria by rifampicin, pyrazinamide, and pyrazinoic acid alone and in combination. Am. Rev. Respir. Dis. 132:1274-1277. - PubMed
-
- Centers for Disease Control and Prevention. 1993. Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis. Morb. Mortal. Wkly. Rep. 42(RR-7):1-8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources